A five-point change in Modified Mini-Mental State Examination was clinically meaningful in community-dwelling elderly people

被引:44
作者
Andrew, Melissa K.
Rockwood, Kenneth [1 ]
机构
[1] Dalhousie Univ, Div Geriatr Med, Halifax, NS B3H 2E1, Canada
基金
加拿大健康研究院;
关键词
3MS; cognition; clinical meaningfulness; clinical detectability; cognitive decline; effect size;
D O I
10.1016/j.jclinepi.2007.10.022
中图分类号
R19 [保健组织与事业(卫生事业管理)];
学科分类号
摘要
Objective: To determine what change in the Modified Mini-Mental State Examination (3MS), a validated and widely used cognitive screening tool for which meaningful change scores have not been clearly characterized, should be considered meaningful. Study Design and Setting: The 3MS was administered at baseline after 5 and 10 years, as part of the population-based Canadian Study of Health and Aging. We calculated Cohen's effect sizes to estimate detectable changes in 3MS screening scores over 5 and 10 years in this large and representative study sample. Results: A total of 3,255 older adults who were community dwelling at baseline completed the 3MS as part of a screening interview at all three interviews. Mean 3MS score was 90.4 (standard deviation [SD] 6.9) at t(1), 89.1 (SD 8.2) at 5 years, and 85.8 (SD 13.0) at 10 years. A change of just over one point, over 5 and 10 years, represented a clinically detectable change with a medium effect size (Cohen's d = 0.5). Conclusions: Although a change of >= 1 point was clinically detectable, consideration of additional criteria for clinical meaningfulness suggested that a change of >= 5 points likely represents a clinically meaningful difference for groups, and is a reasonable choice of cutoff in studies using the 3MS to define cognitive change in individuals. (c) 2008 Elsevier Inc. All rights reserved.
引用
收藏
页码:827 / 831
页数:5
相关论文
共 21 条
  • [1] [Anonymous], 2006, Measuring Health
  • [2] Statins and cognitive function in the elderly - The Cardiovascular Health Study
    Bernick, C
    Katz, R
    Smith, NL
    Rapp, S
    Bhadelia, R
    Carlson, M
    Kuller, L
    [J]. NEUROLOGY, 2005, 65 (09) : 1388 - 1394
  • [3] Cohen J., 1988, POWERSTATISTICALSCIE, DOI 10.4324/9780203771587
  • [4] Reliable individual change scores on the 3MS in older persons with dementia: Results from the Canadian Study of Health and Aging
    Correa, JA
    Perrault, A
    Wolfson, C
    [J]. INTERNATIONAL PSYCHOGERIATRICS, 2001, 13 : 71 - 78
  • [5] Education and the cognitive decline associated with MRI-defined brain infarct
    Elkins, J. S.
    Longstreth, W. T., Jr.
    Manolio, T. A.
    Newman, A. B.
    Bhadelia, R. A.
    Johnston, S. C.
    [J]. NEUROLOGY, 2006, 67 (03) : 435 - 440
  • [6] Cognitive impairment and decline are associated with carotid artery disease in patients without clinically evident cerebrovascular disease
    Johnston, SC
    O'Meara, ES
    Manolio, TA
    Lefkowitz, D
    O'Leary, DH
    Goldstein, S
    Carlson, MC
    Fried, LP
    Longstreth, WT
    [J]. ANNALS OF INTERNAL MEDICINE, 2004, 140 (04) : 237 - 247
  • [7] Socioeconomic differences in cognitive decline and the role of biomedical factors
    Koster, A
    Penninx, BWJH
    Bosma, H
    Kempen, GIJM
    Newman, AB
    Rubin, SM
    Satterfield, S
    Atkinson, HH
    Ayonayon, HN
    Rosano, C
    Yaffe, K
    Harris, TB
    Rooks, RN
    Van Eijk, JT
    Kritchevsky, SB
    [J]. ANNALS OF EPIDEMIOLOGY, 2005, 15 (08) : 564 - 571
  • [8] Risk factors for dementia in the cardiovascular health cognition study
    Kuller, LH
    Lopez, OL
    Newman, A
    Beauchamp, NJ
    Burke, G
    Dulberg, C
    Fitzpatrick, A
    Fried, L
    Haan, MN
    [J]. NEUROEPIDEMIOLOGY, 2003, 22 (01) : 13 - 22
  • [9] Evaluation of dementia in the cardiovascular health cognition study
    Lopez, OL
    Kuller, LH
    Fitzpatrick, A
    Ives, D
    Becker, JT
    Beauchamp, N
    [J]. NEUROEPIDEMIOLOGY, 2003, 22 (01) : 1 - 12
  • [10] Maxwell CJ, 1999, CAN MED ASSOC J, V161, P501